Search Results
Nov 06, 2025, 10:00 ET Netcore Unbxd Launches 'Enrichment for Agentic Commerce' to Make Retailers Visible in the Age of AI Shopping
content:https://www.prnewswire.com/news-releases/netcore-unbxd-launches-enrichment-for-agentic-commerce-to-make-retailers-visible-in-the-age-of-ai-shopping-302606898.html
More news about: Netcore Cloud
Nov 06, 2025, 10:00 ET Dynarex Celebrates EMS Captain Jeremy Sonenschein for Outstanding Service and Leadership
more than 30 years to fire, EMS, and emergency management — building a career defined by education, leadership, and advocacy. He began his service at age 16 as a volunteer with the American Red Cross in Los Angeles, later serving as a Reserve Firefighter/EMT with the Los Angeles City Fire Department and
More news about: Dynarex Corporation
Nov 06, 2025, 09:30 ET Cox Mobile Survey Reveals Adults 65+ More Confident on Connected Devices
managing money and streaming content to navigating cybersecurity risks with growing confidence, this generation is proving that digital literacy has no age limit. Their cautious approach to emerging tech like AI shows they're not just connected, but they're critically engaged."
More news about: Cox Communications
Nov 06, 2025, 09:11 ET APR公司2025年第三季度財務業績再創新高 全年營收有望突破1萬億韓元
Pad外，各種產品線——尤其是全球累計銷量已突破1500萬的PDRN系列，在美國、韓國和國際市場均表現強勁。 美容儀器部門同樣保持穩定增長，營收達1031億韓元（約合7100萬美元），同比增長39%。截至2025年9月，medicube AGE-R家用美容儀的全球累計銷量已超過500萬台。目前，儀器總銷量的一半以上來自海外，既體現了全球零售客戶的強勁需求，也印證了新品上市的成功。 海外營收激增210%，占總銷售額80% APR
More news about: APR Corp.
Nov 06, 2025, 09:00 ET NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
seizure clusters, acute repetitive seizures) that are distinct from an individual's usual seizure pattern in adult and pediatric patients 2 years of age and older. VALTOCO is a proprietary formulation of diazepam incorporating the science of INTRAVAIL®, a transmucosal absorption enhancement
More news about: Neurelis, Inc.
Nov 06, 2025, 09:00 ET Evercoast Wins 8th Annual DataTribe Challenge
and Web3. "This year's finalists provided an insightful window into the future of data security and cybersecurity in the AI age," said Leo Scott, Managing Director, DataTribe. "As robotics become more prevalent in business and everyday life, training these embodied AI systems
More news about: DataTribe
Nov 06, 2025, 09:00 ET Hone Health Integrates Prenuvo Whole-Body MRI Scans to Power Preventive, Data-Driven Longevity Care
diagnostics, securely store their records, understand their data using AI, and coordinate care across providers and systems to help reduce biological age and extend health span. Prenuvo's optimized software provides advanced whole body MRI scans that deliver comprehensive health
More news about: Hone Health
Nov 06, 2025, 09:00 ET Truffle Security Raises $25 Million Series B to Expand NHI Security
codebases from secret exposure at scale. We're thrilled to back the team as they continue to define what modern software security looks like in the age of AI." The new investment will fuel continued growth of
More news about: Truffle Security Co
Nov 06, 2025, 09:00 ET Metropolis Secures $1.6B in Financing From Leading Global Investors
transactions by embedding speed and simplicity into everyday experiences." Metropolis is leading the Recognition Economy, a new age of personalized intelligence where presence replaces devices and credentials as the foundation for a more intuitive, connected and human world. It's
More news about: Metropolis
Nov 06, 2025, 09:00 ET GC Biopharma Supports New Insights into Education, Safety, and Patient Outcomes in Ig Therapy Care at the 2025 IgNS Annual Meeting
● Thrombosis may occur with immune globulin intravenous (IGIV) products, including ALYGLO. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling vascular catheters, hyperviscosity,
More news about: GC Biopharma USA Inc.
Nov 06, 2025, 08:50 ET Verseon's Innovations in Neural Network Architectures Offer Superior Solutions for Life Sciences
covers Verseon's superior predictions of drug-target interactions; another covers how the company's AI produces more accurate estimation of biological age. FREMONT, Calif., Nov.
More news about: Verseon International Corporation
Nov 06, 2025, 08:36 ET Arkstone's AI Clinical Decision Support Helps Treat Over 1 Million Patients
for thousands of potential microbial detections (bacterial, viral, or fungal), considering essential patient-specific factors. These factors include age (ranging from neonates to adults), allergies, diagnosis, pregnancy or lactation status, as well as the presence of resistance genes and antimicrobial
More news about: Arkstone
Nov 06, 2025, 08:00 ET ARBOR Technology Wins Taiwan Excellence Award with High-Performance Edge AI Computing Solutions
performance with four-channel 4K synchronous output. Powered by the Intel® Core™ Ultra processor, it runs four OpenVINO AI models—face, age/gender, expression, and object recognition—enabling real-time, AI-driven advertising, passenger flow analytics, and cashierless retail. Its ultra-compact
More news about: ARBOR Technology
Nov 06, 2025, 08:00 ET ARBOR Technology Wins Taiwan Excellence Award with High-Performance Edge AI Computing Solutions
performance with four-channel 4K synchronous output. Powered by the Intel® Core™ Ultra processor, it runs four OpenVINO AI models—face, age/gender, expression, and object recognition—enabling real-time, AI-driven advertising, passenger flow analytics, and cashierless retail. Its ultra-compact
More news about: ARBOR Technology
Nov 06, 2025, 08:00 ET Servier's New and Updated Data at 2025 ASH Annual Meeting Highlight Commitment to Hematology Research
approximately 20,000 new cases in the U.S., and 43,000 cases in Europe each year.1,2 AML incidence significantly increases with age, and the median age of diagnosis is 69.1 The five-year survival rate is approximately 31.9%.1 For 6 to 10 percent of AML patients, the mutated
More news about: Servier Pharmaceuticals
Nov 06, 2025, 08:00 ET One Third of Americans Have a Side Hustle, Collectively Earning $83.1B Extra per Month, Omnisend Survey Shows
The survey was commissioned by Omnisend and conducted by Cint in July 2025. A total of 1,223 U. S. consumers were surveyed. Quotas were placed on age, gender, and place of residence to achieve a nationally representative sample among users. The estimated $83.1 billion in monthly
More news about: Omnisend
Nov 06, 2025, 08:00 ET The Home Depot Foundation invests an additional $30 million to help thousands of veterans access, stay in homes
railings or damaged doors – can make an enormous difference for a homebound senior veteran. We're proud to continue honoring these heroes by helping them age with comfort, safety, and dignity in their own homes." Helping nearly 5,000 veterans
More news about: The Home Depot Foundation
Nov 06, 2025, 08:00 ET Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
August 2025, the FDA approved the Nuvaxovid 2025-2026 Formula for the prevention of COVID-19 in individuals 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. Nuvaxovid was approved
More news about: Novavax, Inc.
Nov 06, 2025, 07:30 ET FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder
CAPLYTA and antidepressant medicines increase the risk of suicidal thoughts and actions in people 24 years of age and younger, especially within the first few months of treatment or when the dose is changed. Depression and other serious mental illnesses are the most
More news about: Johnson & Johnson
Nov 06, 2025, 07:27 ET MavriX Bio Announces First Patient Dosed in ASCEND-AS Trial of MVX-220, Investigational Gene Therapy for Angelman Syndrome
FAST's goal is to drive forward transformative research and development programs as efficiently as possible for those living with AS — regardless of age or genotype. Learn more at
More news about: AS2Bio
Nov 06, 2025, 07:15 ET Designing for Tomorrow: The 138th Canton Fair Showcases Innovations Rooted in Care for Childhood
responds to a child's cry. The design not only provides hands-free comfort for parents but also extends usability from infancy up to three years of age, showcasing a thoughtful balance between convenience, safety, and functionality. By prioritizing child development and ergonomics,
More news about: Canton Fair
Nov 06, 2025, 07:15 ET Designing for Tomorrow: The 138th Canton Fair Showcases Innovations Rooted in Care for Childhood
responds to a child's cry. The design not only provides hands-free comfort for parents but also extends usability from infancy up to three years of age, showcasing a thoughtful balance between convenience, safety, and functionality. By prioritizing child development and ergonomics,
More news about: Canton Fair
Nov 06, 2025, 07:05 ET REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
Disease: Surabgene lomparvovec (sura-vec, ABBV-RGX-314), developed in collaboration with AbbVie, is potentially the first-in-class treatment for wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR). Sura-vec for the Treatment of Wet
More news about: REGENXBIO Inc.
Nov 06, 2025, 07:00 ET Overland Oasis launches resupply stations for RVers, digital nomads, campers and adventure motorcyclists
million people will go RVing this year, to say nothing of the 81 million campers and adventure motorcyclists who don't happen to own RVs. And, the median age of this demographic is falling fast, down from 65 to 48 in just the last few years. With an initial phase of 15 locations identified
More news about: Overland Oasis
Nov 06, 2025, 07:00 ET Ispire Technology Inc. Reports Financial Results for Fiscal First Quarter 2026
currently contemplated, with different terms, or at all; the Joint Venture's ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company's ability to collect its accounts receivable in a timely manner; the Company's
More news about: Ispire Technology Inc.